Biotechnology at Roosevelt University

Roosevelt's biotechnology program comes with an estimated $24,125 in debt—about 17% above the national median for biotech bachelor's programs—while peer programs nationally suggest first-year earnings around $47,000. That debt-to-earnings ratio of 0.51 means graduates might need to dedicate roughly half their first-year salary to debt repayment, a manageable but meaningful burden that requires careful financial planning.

The challenge here is that we're working entirely with estimates since Roosevelt's actual graduate outcomes aren't publicly available due to small sample sizes. Nationally, biotech bachelor's programs show relatively tight earnings clustering, with most graduates earning between $47,000 and $52,000 in their first year, suggesting this field has fairly predictable entry-level compensation regardless of institution. The real question becomes whether Roosevelt's higher-than-typical estimated debt load reflects actual program costs or simply limited comparison data.

Given Roosevelt's open-access mission (94% admission rate) and significant Pell Grant population (46%), this program likely serves students who might otherwise lack access to STEM education. If the debt estimates prove accurate, graduates would still enter a stable field with clear career paths in pharmaceuticals, research labs, and healthcare—but they'd start with more financial pressure than peers at programs reporting lower debt loads. Before committing, confirm actual program costs and seek out Roosevelt alumni to understand real-world outcomes beyond these national estimates.